The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form

Journal of Cell Science

Volumn 111, Issue 18, 1998, Pages 2789-2798

  Stanton, Heather ^a   Gavrilovic, Jelena ^a   Atkinson, Susan J ^a   D'Ortho, Marie Pia ^b   Yamada, Kenneth M ^c   Zardi, Luciano ^d   Murphy, Gillian ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b FACULTÉ DE MÉDECINE   (France)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

5 1 integrin; Fibronectin; MMP 2 activation; MT1 MMP

Indexed keywords

FIBRONECTIN; GELATINASE A; LAMININ; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER CELL CULTURE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; SARCOMA CELL;

CELL ADHESION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBRONECTINS; GELATINASES; HUMANS; LAMININ; LIGANDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MOLECULAR WEIGHT; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, FIBRONECTIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0031727149     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Akiyama, S. K., Yamada, S. S., Chen, W.-T. and Yamada, K. M. (1989). Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly and cytoskeletal organization. J. Cell Biol. 109, 863-875.
2. Akiyama, S. K., Olden, K. and Yamada, K. M. (1995). Fibronectin and integrins in invasion and metastasis. Cancer Metast. Rev. 14, 173-189.
3. Allan, J. A., Docherty, A. J. P., Barker, P. J., Huskisson, N. S., Reynolds, J. J. and Murphy, G. (1995). Binding of gelatinases A and B to type I collagen and other matrix components. Biochem. J. 309, 299-306.
4. Arner, E. C. and Tortorella, M. D. (1995). Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin-1. Arthritis Rheum. 38, 1304-1314.
5. Atkinson, S. J., Crabbe, T., Cowell, S., Ward, R. V., Butler, M. J., Sato, H., Seiki, M., Reynolds, J. J. and Murphy, G. (1995). Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 270, 30479-30485.
6. r 72, 000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res. 52, 4540-4544.
7. Borsi, L., Castellani, P., Balza, E., Siri, A., Pellecchia, C., De Scalzi, F. and Zardi, L. (1986). Large-scale procedure for the purification of fibronectin domains. Anal. Biochem. 155, 335-345.
8. Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R., Stetler-Stevenson, W. G., Quigley, J. P. and Cheresh, D. A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of cells by interaction with integrin αtvβ3. Cell 85, 683-693.
9. Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M. and Cheresh, D. A. (1998). Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400.
10. Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., Schade van Westrum, S., Crabbe, T., Clements, J., d'Ortho, M. P. and Murphy, G. (1998). The TIMP2 membrane type I metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J. Biol. Chem. 273, 871-880.
11. Chambers, A. F. and Matrisian, L. M. (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Nat. Cancer Inst. 89, 1260- 1270.
12. Chintala, S. K., Sawaya, R., Gokaslan, Z. L. and Rao, J. S. (1996). Modulation of matrix metalloprotease-2 and invasion in human glioma cells by α3β1 integrin. Cancer Lett. 103, 201-208.
13. Chomczynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
14. d'Ortho, M. P., Will, H., Atkinson, S. J., Butler, G., Messent, A. J., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L. and Murphy, G. (1997). Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757.
15. d'Ortho, M. P., Stanton, H., Butler, M., Atkinson, S. J., Murphy, G. and Hembry, R. M. (1998). MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett. 421, 159-164.
16. Danen, E. H. J., Aota, S., van Kraats, A. A., Yamada, K., Ruiter, D. J. and van Muijen, G. N. P. (1995). Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of the integrin α5β1. J. Biol. Chem. 270, 21612-21618.
17. Fukai, F., Ohtaki, M., Fujii, N., Yajima, H., Ishii, T., Nishizawa, Y., Miyazaki, K. and Katayama, T. (1995). Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry 34, 11453-11459.
18. Gilles, C., Polette, M., Seiki, M., Birembaut, P. and Thompson, E. W. (1997). Implication of collagen type-I induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest. 76, 651-660.
19. Green, D. R., Banuls, M. P., Gearing, A. J. H., Needham, L. A., White, M. R. H. and Clements, J. M. (1994). Generation of human umbilical vein endothelial cell lines which maintain their differentiated phenotype. Endothelium 2, 191-201.
20. Greiling, D. and Clark, R. A. F. (1997). Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J. Cell Sci. 110, 861-870.
21. Haas, T. L., Davis, S. and Madri, J. A. (1998). Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem. 273, 3604-3610.
22. Heussen, C. and Dowdle, E. B. (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 102, 196-202.
23. Huhtala, P., Humphries, M. J., McCarthy, J. B., Tremble, P. M., Werb, Z. and Damsky, C. H. (1995). Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol. 129, 867-879.
24. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M. and Okada, Y. (1996). Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56, 2707-2710.
25. Knäuper, V., Will, H., López-Otín, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M. and Murphy, G. (1996). Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J. Biol. Chem. 271, 17124- 17131.
26. Kubota, S., Ito, H., Ishibashi, Y. and Seyama, Y. (1997) Anti-alpha3 integrin antibody induces the activated form of matrix metalloproteinase-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int. J. Cancer 70, 106-111.
27. Laemmli, U. K. and Favre, M. (1973). Maturation of the head of bacteriophage T4. I. DNA packaging events. J. Mol. Biol. 80, 575-599.
28. LaFlamme, S. E., Akiyama, S. K. and Yamada, K. M. (1992). Regulation of fibronectin receptor distribution. J. Cell Biol. 117, 437-447.
29. Langholz, O., Röckel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T. and Eckes, B. (1995). Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by α1β1 and α2β1 integrins. J. Cell Biol. 131, 1903-1915.
30. Larjava, H., Lyons, J. G., Salo, T., Makela, M., Koivisto, L., Birkedal-Hansen, H., Akiyama, S. K., Yamada, K. M. and Heino, J. (1993). Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J. Cell Physiol. 157, 190-200.
31. Lohi, J., Lehti, K., Westermarck, J., Kähäri, V. and Keski-Oja, J. (1996). Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem. 239, 239-247.
32. Miyamoto, S., Teramoto, H., Coso, O. A., Gutkind, J. S., Burbelo, P. D., Akiyama, S. K. and Yamada, K. M. (1995). Integrin function:molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 131, 791- 805.
33. Miyamoto, S., Teramoto, H., Gutkind, J. S. and Yamada, K. M. (1996). Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135, 1633-1642.
34. Mohri, H. (1996). Fibronectin and integrins interactions. J. Invest. Medicine 44, 429-441.
35. Murphy, G., Cawston, T. E. and Reynolds, J. J. (1981). An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem. J. 195, 167-170.
36. Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M. and Docherty, A. J. P. (1991). The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30, 8097-8102.
37. Murphy, G., Allan, J. A., Willenbrock, F., Cockett, M. I., O'Connell, J. P. and Docherty, A. J. P. (1992a). The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267, 9612-9618.
38. Murphy, G., Willenbrock, F., Ward, R. V., Cockett, M. I., Eaton, D. and Docherty, A. J. P. (1992b). The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J. 283, 637-641.
39. Murphy, G., Ward, R., Gavrilovic, J. and Atkinson, S. (1992c). Physiological mechanisms for metalloproteinase activation. Matrix (suppl.) 1, 224-230.
40. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M. and Okada, Y. (1997). Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451.
41. Paterson, H., Reeves, B., Brown, R., Hall, A., Furth, M., Bos, J., Jones, P. and Marshall, C. (1987). Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell 51, 803-812.
42. Pei, D. and Weiss, S. J. (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271, 9135-9140.
43. Plopper, G. E., McNamee, H. P., Dike, L. E., Bojanowski, K., Ingber, D. E. (1995). Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell 6, 1349-1365.
44. Reich, R., Blumenthal, M. and Liscovitch, M. (1995). Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clin. Exp. Metast. 13, 134-140.
45. Riikonen, T., Westermarck, J., Koivisto, L., Broberg, A., Kähäri, V. M. and Heino, J. (1995). Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J. Biol. Chem. 270, 13548- 13552.
46. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65.
47. Sato, H. and Seiki, M. (1996). Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J. Biochem. 119, 209-215.
48. Schwartz, M. A., Schaller, M. D. and Ginsberg, M. H. (1995). Integrins-emerging paradigms of signal-transduction. Annu. Rev. Cell Dev. Biol. 11, 549-599
49. Seftor, R. E. B., Seftor, E. A., Gehlsen, K. R., Stetler-Stevenson, W. G., Brown, P. D., Ruoslahti, E. and Hendrix, M. J. C. (1992). Role of the αvβ3 integrin in human melanoma cell invasion. Proc. Nat. Acad. Sci. USA 89, 1557-1561.
50. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. and Goldberg, G. I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270, 5331-5338.
51. Tremble, P., Chiquet-Ehrismann, R. and Werb, Z. (1994). The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol. Cell 5, 439-453.
52. von der Mark, H., Durr, J., Sonnenberg, A., von der Mark, K., Deutzmann, R. and Goodman, S. L. (1991). Skeletal myoblasts utilize a novel beta 1-series integrin and not alpha 6 beta 1 for binding to the E8 and T8 fragments of laminin. J. Biol. Chem. 266, 23593-23601.
53. 2+ for fibronectin and heparin binding. J. Biol. Chem. 272, 7473-7481.
54. Ward, R. V., Hembry, R. M., Reynolds, J. J. and Murphy, G. (1991). The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem. J. 278, 179-187.
55. Ward, R. V., Atkinson, S. J., Reynolds, J. J. and Murphy, G. (1994). Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem. J. 304, 263-269.
56. Werb, Z., Tremble, P. M., Behrendtsen, E., Crowley, E. and Damsky, C. H. (1989). Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109, 877-889.
57. Werb, Z., Sympson, C. J., Alexander, C. M., Thomasset, N., Lund, L. R., MacAuley, A., Ashkenas, J. and Bissell, M. J. (1996). Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution. Kidney Int. 49 (suppl. 54). S68-S74.
58. Werb, Z. (1997). ECM and cell surface proteolysis: regulating cellular ecology. Cell 91, 439-442.
59. West-Mays, J. A., Strissel, K. J., Sadow, P. M. and Fini, M. E. (1995). Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1α autocrine loop. Proc. Nat. Acad. Sci. USA 92, 6768-6772.
60. Will, H., Atkinson, S. J., Butler, G. S., Smith, B. and Murphy, G. (1996). The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and intiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271, 17119-17123.
61. Willenbrock, F., Crabbe, T., Slocombe, P. M., Sutton, C. W., Docherty, A. J. P., Cockett, M. I., O'Shea, M., Brocklehurst, K., Phillips, I. R. and Murphy, G. (1993). The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 32, 4330-4337.
62. Yamada, K. M. and Kennedy, D. W. (1984) Dualistic nature of adhesive protein function. J. Cell Biol. 99, 29-36.
63. Yamada, K. M., Kennedy, D. W., Yamada, S. S., Gralnick, H., Chen, W. T. and Akiyama, S. K. (1990). Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Res. 50, 4485-4496.